meetings

DR. WAGNER: Let's all gather.

           Okay, I believe all who are available here are assembled, and Dr. Beauchamp will join us by video conference.  Tom, can you see and hear us?

           DR. BEAUCHAMP:  Yes, I can see and hear you.

DR. WAGNER:  Welcome back, Commissioners. We're about to commence on our final session and what we want to do is talk about a specific future topic, obviously there are many we could pursue, but as you will see, I think we have a special interest, if not obligation to be looking at a future topic on Incidental Findings.

DR. GUTMANN:  Welcome, everybody. I'm Amy Gutmann.  I'm President of the University of Pennsylvania and Chair of the Presidential Commission for the Study of Bioethical Issues. On behalf of myself and our Vice Chair, James Wagner, the President of Emory University, I'd like to welcome you to our 12th meeting.

DR. WAGNER:  So, let’s get started. 

                        We are shifting now from, um, uh, pre-event discussions to post event.  MCM use, medical countermeasures use and research and post-event scenarios, and we will again, the format, we’ll ask each of you to make your presentations, and then open it for questions.

DR.

DR. GUTMANN:  Welcome back everybody.  We have until 11:45, right?  Great.  So, we'll take an hour and then wrap up. 

DR.

DR. WAGNER: 

            We appreciate you all hanging around for a roundtable.  We have found these to be, uh, uh, very helpful, uh, although they tend to be extremely wide ranging and, uh, and I’m concerned that there isn’t – we try – in order to keep them from just going, spinning immediately out of control, we try to, uh, pose a framing question.  It’s very hard to pose a framing question for this one but, maybe we can start with something like this.

DR. WAGNER:  Let me invite our next session, experts forward, Bruce Lockwood, Dr. Benjamin. 

DR. WAGNER:  I believe we are assembled. I’m Jim Wagner.  It’s my privilege to be serving Emory University as its president.  I also am privileged to be the Vice Chair of this President’s Commission on the Study of Bioethical Issues.  Our chairman, Amy Gutmann, has asked me to convey, uh, regrets, at least for this first day of our meetings.  She had something come up on Saturday, uh which obligates her today and requires her attention today, but she’ll be flying in I believe this evening to be with us tomorrow.